信安世紀(688201.SH):加大信創產品的重視 在研發及產品更新時優先適用信創環境
格隆匯4月19日丨有投資者向信安世紀(688201.SH)提問:信創的發展對公司有哪些影響?
信安世紀回覆:近年來涉及密碼行業的宏觀政策、行業政策持續推出,國密改造、等保2.0、信創等政策,推動了密碼行業快速發展。公司產品主要用於保障客户業務系統的安全,比業務系統的建設略有滯後性,在政策指引和行業內生需求雙重驅動下,金融信創不斷推進,作為優勢行業,需求增長平穩;政企信創在硬件、辦公軟件需求滿足後,對安全產品產生需求。公司加大信創產品的重視,在研發及產品更新時,優先適用信創環境。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.